Vor Biopharma Inc.

0.97
-0.11 (-10.19%)
At close: Mar 03, 2025, 3:59 PM
0.95
-2.14%
After-hours: Mar 03, 2025, 04:00 PM EST

Vor Biopharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 31.36M 57.71M 119.8M 48.54M 6.47M 929K
Short-Term Investments 105.81M 172.54M 87.67M n/a n/a n/a
Long-Term Investments n/a 2.41M 2.41M 1.56M 1.56M n/a
Other Long-Term Assets 7.22M 2.92M 3.25M 3.4M n/a n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 3.63M 6.71M 6.93M 567K 1.07M 7K
Total Current Assets 140.8M 236.95M 214.4M 49.11M 7.54M 936K
Property-Plant & Equipment 50.1M 57.08M 22.52M 21.84M 728K 71K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 57.32M 62.42M 28.19M 26.8M 2.29M 71K
Total Assets 198.13M 299.37M 242.59M 75.91M 9.83M 1.01M
Account Payables 815K 1.77M 1.54M 2.36M 693K 38K
Deferred Revenue n/a n/a 6.33M 6.26M n/a 1.4M
Short-Term Debt 3.83M 6.54M 3.68M 1.73M n/a 4.46M
Other Current Liabilities 10.93M 4.8M 4.93M 6.12M 1.49M 3.28M
Total Current Liabilities 15.57M 13.12M 10.15M 10.21M 2.19M 7.77M
Long-Term Debt 31.83M 71.28M 32.35M 34.86M n/a n/a
Other Long-Term Liabilities n/a -35.64M -16.17M -17.43M n/a n/a
Total Long-Term Liabilities 31.83M 35.64M 16.17M 17.43M n/a n/a
Total Liabilities 47.4M 48.76M 26.33M 27.64M 2.19M 7.77M
Total Debt 35.66M 38.91M 18.01M 18.29M n/a 4.46M
Common Stock 7K 7K 4K 1K n/a n/a
Retained Earnings -340.08M -222.22M -130.12M -61.22M -17.89M -7.05M
Comprehensive Income -77K -770K -242.59M n/a 0.00 n/a
Shareholders Equity 150.72M 250.61M 216.26M 48.27M 7.64M -6.77M
Total Investments 105.81M 172.54M 87.67M 1.56M 1.56M n/a